HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Prognostic significance of immunohistochemical RhoA expression on survival in pancreatic ductal adenocarcinoma: a high-throughput analysis.

Abstract
Among all human carcinomas, pancreatic cancer has one of the worst survival rates. Most patients will die of this cancer shortly after diagnosis, and currently, surgery is the only potential cure. Ductal adenocarcinoma is the most common histologic type. The search for prognostic parameters has progressed from mere physical or histomorphological tumor properties to molecular parameters. These, in turn, might point toward new therapeutic strategies. The K-ras oncogene is known to play a role in early stages of ductal adenocarcinoma carcinogenesis, and ras homologues are differentially expressed in cancerous versus normal ductal cells. RhoA belongs to a family of ras homologues comprising RhoA, RhoB, and RhoC. It is a guanosine triphosphatase associated with the cytoskeleton that seems to be involved in epithelial mesenchymal transition, a process of dedifferentiation. Immunohistologic RhoA expression was studied in a tissue microarray of 94 pancreatic ductal adenocarcinomas and correlated with clinicopathologic parameters and follow-up. RhoA protein expression, measured as labeling intensity or evaluated as percentage of reactive tumor cells, correlated with overall survival. A multivariate analysis demonstrated that RhoA protein expression is independent from other known prognostic parameters such as tumor size or grade. Moreover, a score combining RhoA expression with tumor size and grade resulted in a highly significant increase in the prognostic value for the overall survival of patients with pancreatic ductal adenocarcinoma.
AuthorsDag-Daniel Dittert, Christian Kielisch, Ingo Alldinger, Christian Zietz, Wolfdietrich Meyer, Frank Dobrowolski, Hans-Detlev Saeger, Gustavo Bruno Baretton
JournalHuman pathology (Hum Pathol) Vol. 39 Issue 7 Pg. 1002-10 (Jul 2008) ISSN: 1532-8392 [Electronic] United States
PMID18495213 (Publication Type: Journal Article)
Chemical References
  • Biomarkers, Tumor
  • RHOA protein, human
  • rhoA GTP-Binding Protein
Topics
  • Adult
  • Aged
  • Aged, 80 and over
  • Biomarkers, Tumor (metabolism)
  • Carcinoma, Pancreatic Ductal (metabolism, mortality)
  • Female
  • Germany (epidemiology)
  • Humans
  • Immunohistochemistry
  • Male
  • Middle Aged
  • Pancreatectomy
  • Pancreatic Neoplasms (metabolism, mortality)
  • Prognosis
  • Survival Rate
  • Tissue Array Analysis
  • rhoA GTP-Binding Protein (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: